High tumor expression of CTLA4 identifies lymph node-negative basal-like breast cancer patients with excellent prognosis.

Saved in:
Bibliographic Details
Title: High tumor expression of CTLA4 identifies lymph node-negative basal-like breast cancer patients with excellent prognosis.
Authors: Røssevold AH; Department of Clinical Cancer Research, Department of Oncology, Oslo University Hospital, Oslo, Norway.; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Tekpli X; Department of Medical Genetics, Clinic for Laboratory Medicine, Oslo University Hospital, Oslo, Norway.; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Lingjærde OC; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Center for Bioinformatics, Department of Informatics, University of Oslo, Oslo, Norway., Russnes HG; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Department of Pathology, Oslo University Hospital, Oslo, Norway., Vallon-Christersson J; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden., Borgen E; Department of Pathology, Oslo University Hospital, Oslo, Norway., Lømo J; Department of Pathology, Oslo University Hospital, Oslo, Norway., Garred Ø; Department of Pathology, Oslo University Hospital, Oslo, Norway., Dorraji E; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Kristensen VN; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Medical Genetics, Clinic for Laboratory Medicine, Oslo University Hospital, Oslo, Norway., Naume B; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway., Kyte JA; Department of Clinical Cancer Research, Department of Oncology, Oslo University Hospital, Oslo, Norway. jonky@ous-hf.no.; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. jonky@ous-hf.no.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. jonky@ous-hf.no.; Faculty of Health Sciences, Oslo Metropolitan University, Oslo, Norway. jonky@ous-hf.no.
Source: Communications medicine [Commun Med (Lond)] 2025 Jun 16; Vol. 5 (1), pp. 234. Date of Electronic Publication: 2025 Jun 16.
Publication Type: Journal Article
Journal Info: Publisher: Nature Portfolio Country of Publication: England NLM ID: 9918250414506676 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-664X (Electronic) Linking ISSN: 2730664X NLM ISO Abbreviation: Commun Med (Lond) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2730-664X
DOI:10.1038/s43856-025-00865-z